MedPath
HSA Approval

SW DIMENHYDRINATE SYRUP 15 mg/5 ml

SIN02790P

SW DIMENHYDRINATE SYRUP 15 mg/5 ml

SW DIMENHYDRINATE SYRUP 15 mg/5 ml

May 11, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AA02

diphenhydramine

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

DIMENHYDRINATE

15 mg/5 ml

Dimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SW DIMENHYDRINATE SYRUP 15 mg/5 ml - HSA Approval | MedPath